ATF3 and breast carcinoma: It was reported that EGR-1 can inhibit the growth of hepatocellular carcinoma cell lines and suppress the transformation activity in fibrosarcoma and breast carcinoma [33], ATF3 and KLF4 were reported as tumor suppressors in HCC [34, 35].